Effect of opium addiction on diabetes

American Journal of Drug and Alcohol Abuse

Volumn 34, Issue 4, 2008, Pages 383-388

  Azod, Laila ^a   Rashidi, Maryam ^a,b   Afkhami Ardekani, Mohammad ^a   Kiani, Golchehr ^a   Khoshkam, Fariba ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Afshar Hospital   (Iran)

Author keywords

Glycated hemoglobin; Opium addiction; Type 2 Diabetes

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; OPIATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; LIPID BLOOD LEVEL; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OPIATE ADDICTION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ALBUMINS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; OPIUM; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 46249086805     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990802122580     Document Type: Article

References (18)

1. Larijani B, Zahedi F, Aghakhani SH. Epidemiology of diabetes mellitus in Iran. Shraz E-Medical Journal 2003; 4(4).
2. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2005: Prevalence, numerical estimates and projections. Diabetes Care 1998; 21(9):1414-1431.
3. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes care 1998; 21:296-309.
4. Elson DF, Meredith M. Therapy for type 2 diabetes mellitus. Wis Med J 1998; 97:49-54.
5. Asadi Karam GR, Reisi M, Alizadeh KA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addiction Biology 2004; 9:53-58.
6. Vassalle M. Role of catecholamine release in morphine hyperglycemia. Am J Physiol 1961; 200:530-534.
7. Feldberg W, Shaligram SV. The hyperglycemic effect of morphine. Br J Pharmacol 1972; 46:602-618.
8. Feldberg W, Gupta KP. Morphine hyperglycemia. J Physiol (Lond.) 1974; 238:487-502.
9. Feldberg W, Smyth DG. C-fragment of lipotropinan endogenous potent analgesic peptide. Br J Pharmacol 1977; 60:445-453.
10. Van Loon GR, Appel NM. Fl-Endorphin-induced hyperglycemia ismediated by increased central sympathetic outflow to adrenal medulla. Brain Res 1981; 204:236-241.
11. Reid RL, Yen SSC. B-endorphin stimulates the secretion of insulin and glucagon in humans. J Clin Endocrinol Metab 1981; 52:592-594.
12. Ipp E, Dobbs R, Unger RH. Morphine and endorphin influence the secretion of the endocrine pancreas. Nature (Lond.) 1978; 276:190-192.
13. Ipp E, Schusdziarra V, Harris V, Unger RH. Morphine-induced hyperglycemia: Role of insulin and glucagon. Endocrinology 1980; 107:461-463.
14. Feldman M, Kiser RS, Unger RH, Li CH. 3-Endorphin and the endocrine pancreas. N Engl J Med 1983; 308:349-353.
15. Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, Abumrad NN. Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 1984; 74:1473-1480.
16. Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Addiction 2006; 101(Suppl. 1):59-75.
17. Molina PE, Hashinguchi Y, Ajmal M, Maza M, Abumrad NN. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6- glucoronide. Brain Res 1994; 664:126-132.
18. Hashiguchi Y, Molina PE, Abumrad NN. Modulation of metabolic effects of morphine-6-glucoronide by morphine-3-glucoronide. Brain Res Bull 1995; 38:325-329.